Rotavirus vaccines--balancing intussusception risks and health benefits
- PMID: 24422677
- PMCID: PMC5716463
- DOI: 10.1056/NEJMe1315836
Rotavirus vaccines--balancing intussusception risks and health benefits
Comment on
-
Intussusception risk after rotavirus vaccination in U.S. infants.N Engl J Med. 2014 Feb 6;370(6):503-12. doi: 10.1056/NEJMoa1303164. Epub 2014 Jan 14. N Engl J Med. 2014. PMID: 24422676
-
Risk of intussusception after monovalent rotavirus vaccination.N Engl J Med. 2014 Feb 6;370(6):513-9. doi: 10.1056/NEJMoa1311738. Epub 2014 Jan 14. N Engl J Med. 2014. PMID: 24422678
References
-
- Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33. - PubMed
-
- Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22. - PubMed
-
- Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564–72. - PubMed
-
- Tate JE, Mutuc JD, Panozzo CA, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J. 2011;30(Suppl):S30–S34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources